Jean-luc L. Faillie

Montpellier, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications

Glucagon-Like Peptide-1 Receptor Agonists in Cocaine Use Disorder: Clinical Observations and Underlying Mechanisms.

Glucagon-Like Peptide-1 Receptor Agonists in Cocaine Use Disorder: Clinical Observations and Underlying Mechanisms.

Journal: Fundamental & clinical pharmacology
Published: March 06, 2026

Redefining the real problem in psychedelic trials: Why fighting the Lessebo matters more than blinding integrity.

Redefining the real problem in psychedelic trials: Why fighting the Lessebo matters more than blinding integrity.

Journal: The International journal on drug policy
Published: February 24, 2026

Applying machine learning to pharmacovigilance data: A proof-of-concept study.

Applying machine learning to pharmacovigilance data: A proof-of-concept study.

Journal: British journal of clinical pharmacology
Published: January 09, 2026

Analysis of interstitial lung disease in pharmacovigilance databases: Coding challenges and interpretation biases-An update.

Analysis of interstitial lung disease in pharmacovigilance databases: Coding challenges and interpretation biases-An update.

Journal: British journal of clinical pharmacology
Published: October 20, 2025

JAK Inhibitors and Memory Impairment: Disproportionality Analyses in the WHO Global Pharmacovigilance Database, VigiBase.

JAK Inhibitors and Memory Impairment: Disproportionality Analyses in the WHO Global Pharmacovigilance Database, VigiBase.

Journal: Fundamental & clinical pharmacology
Published: August 04, 2025

Ketoacidosis associated with type 2 sodium-glucose cotransporter inhibitors (SGLT2i) in patients aged 65 and older: Evidence from the French national pharmacovigilance database.

Ketoacidosis associated with type 2 sodium-glucose cotransporter inhibitors (SGLT2i) in patients aged 65 and older: Evidence from the French national pharmacovigilance database.

Journal: Diabetes & metabolism
Published: July 25, 2025

Allergy-like nocebo events reported with COVID-19 vaccines: a case control study.

Allergy-like nocebo events reported with COVID-19 vaccines: a case control study.

Journal: Expert opinion on drug safety
Published: April 23, 2025

Risk of thyroid cancer related to glucagon-like peptide-1 receptor agonists: A systematic review with meta-analysis of harms of randomized controlled trials.

Risk of thyroid cancer related to glucagon-like peptide-1 receptor agonists: A systematic review with meta-analysis of harms of randomized controlled trials.

Journal: Diabetes, obesity & metabolism
Published: March 07, 2025

Use and Potential Misuse of Glucagon-Like Peptide-1 Receptor Agonists in France: A Nationwide Cohort Study.

Use and Potential Misuse of Glucagon-Like Peptide-1 Receptor Agonists in France: A Nationwide Cohort Study.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: December 12, 2024

Suicide and suicide attempt in users of GLP-1 receptor agonists: a nationwide case-time-control study.

Suicide and suicide attempt in users of GLP-1 receptor agonists: a nationwide case-time-control study.

Journal: EClinicalMedicine
Published: October 23, 2024

Shaping the future of pharmacoepidemiology in France: Recommendations from the SFPT Pharmacoepidemiology Working Group.

Shaping the future of pharmacoepidemiology in France: Recommendations from the SFPT Pharmacoepidemiology Working Group.

Journal: Therapie
Published: September 26, 2024

GLP-1 Receptor Agonists and Suicidality-Caution Is Needed.

GLP-1 Receptor Agonists and Suicidality-Caution Is Needed.

Journal: JAMA network open
Published: August 20, 2024
Showing 1-12 of 79

Last Updated: 09/26/2026